|
|
Previous Article | Table of Contents | Next Article 
The Mpl-ligand or thrombopoietin or megakaryocyte growth and
differentiative factor has both direct proliferative and differentiative
activities on human megakaryocyte progenitors
N Debili, F Wendling, A Katz, J Guichard, J Breton-Gorius, P Hunt and W Vainchenker
INSERM U 362, Institut Gustave Roussy, Villejuif, France.
Previously, it was believed that megakaryocytopoiesis was regulated by two
types of humoral factors: megakaryocyte colony-stimulating factor (MK-CSF),
which acts on progenitors inducing their proliferation, and thrombopoietin
(TPO), a megakaryocyte(s) (MK) maturational factor that induces platelet
formation. The recently cloned Mpl-ligand (Mpl-L) seems to have both
properties in vivo and in vitro and has also been called TPO. However, it
cannot be excluded that a part of these activities is due to a synergistic
effect with growth factors present in the serum or synthesized by accessory
cells. To delineate the precise TPO (Mpl-L) biologic activities, we
performed serum-free cultures at limiting cell dilution. Target cells were
adult human marrow CD34+CD41+ cells, which represent a highly selected
population of late MK progenitor or transitional cells. Cells were purified
using a flow cytometer equipped with an automatic cloning design unit. We
determined that the recombinant molecule had a biologic activity that
reached a plateau at 10 ng/mL. At this concentration, a linear relationship
between the average MK number per well and the number of cells seeded
(between 1 to 50 cells per well) was observed. At one cell per well, 60% of
the wells contained a single MK at day 5 of culture. Half of these wells
contained only one large MK, whereas the other half contained several MK
(up to 25), demonstrating that TPO has direct proliferative biologic
activity. In contrast, at limiting dilution, none of the other cytokines
tested (stem cell factor [SCF], interleukin- 6 [IL-6], and erythropoietin
[Epo]) were effective, whereas IL-3 showed a mild effect. However, a
combination of SCF plus IL-6 plus IL-3 produced similar results as TPO
alone. Addition of the other cytokines to TPO did not enhance the cloning
efficiency of the CD34+CD41+ cells but increased twofold the average number
of MKs per clone. MKs reached a ploidy of 32N and 64N in the presence of
TPO. The mean ploidy value was approximately 6 and was not modified by
addition of the other cytokines. At the ultrastructural level, a majority
of the MKs showed maturational defects related to an imbalance between the
synthesis of alpha-granules and demarcation membranes. However, a fraction
(about 30%) had a cytoplasmic maturation that exactly mimicked that of
marrow MKs. In addition, proplatelet-shedding MKs were observed in the
cultures, even at limiting dilution. Such a result was not observed with
any other individual cytokines, including the combination of three
cytokines.(ABSTRACT TRUNCATED AT 400 WORDS)
Volume 86,
Issue 7,
pp. 2516-2525,
10/01/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Takayama, H. Nishikii, J. Usui, H. Tsukui, A. Sawaguchi, T. Hiroyama, K. Eto, and H. Nakauchi
Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors
Blood,
June 1, 2008;
111(11):
5298 - 5306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Nurden, N. Debili, W. Vainchenker, R. Bobe, R. Bredoux, E. Corvazier, R. Combrie, E. Fressinaud, D. Meyer, A. T. Nurden, et al.
Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia
Blood,
October 15, 2006;
108(8):
2587 - 2595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pang, H.-H. Xue, G. Szalai, X. Wang, Y. Wang, D. K. Watson, W. J. Leonard, G. A. Blobel, and M. Poncz
Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins
Blood,
October 1, 2006;
108(7):
2198 - 2206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Komura, C. Tonetti, V. Penard-Lacronique, H. Chagraoui, C. Lacout, J. P. LeCouedic, P. Rameau, N. Debili, W. Vainchenker, and S. Giraudier
Role for the Nuclear Factor {kappa}B Pathway in Transforming Growth Factor-{beta}1 Production in Idiopathic Myelofibrosis: Possible Relationship with FK506 Binding Protein 51 Overexpression
Cancer Res.,
April 15, 2005;
65(8):
3281 - 3289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Orita, H. Tsunoda, N. Yabuta, K. Nakano, T. Yoshino, Y. Hirata, T. Ohtomo, J.-i. Nezu, H. Sakumoto, K. Ono, et al.
A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor
Blood,
January 15, 2005;
105(2):
562 - 566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sabri, M. Jandrot-Perrus, J. Bertoglio, R. W. Farndale, V. M.-D. Mas, N. Debili, and W. Vainchenker
Differential regulation of actin stress fiber assembly and proplatelet formation by {alpha}2{beta}1 integrin and GPVI in human megakaryocytes
Blood,
November 15, 2004;
104(10):
3117 - 3125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Paulus, N. Debili, F. Larbret, J. Levin, and W. Vainchenker
Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors
Blood,
October 15, 2004;
104(8):
2291 - 2298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Inagaki, T. Oda, Y. Naka, H. Shinkai, N. Komatsu, and H. Iwamura
Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities
Blood,
July 1, 2004;
104(1):
58 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-T. Fujimoto, S. Kohata, H. Suzuki, H. Miyazaki, and K. Fujimura
Production of functional platelets by differentiated embryonic stem (ES) cells in vitro
Blood,
December 1, 2003;
102(12):
4044 - 4051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Hitchcock, T. M. Skerry, M. R. Howard, and P. G. Genever
NMDA receptor-mediated regulation of human megakaryocytopoiesis
Blood,
August 15, 2003;
102(4):
1254 - 1259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Linden and K. Kaushansky
The Glycan Domain of Thrombopoietin (TPO) Acts in trans to Enhance Secretion of the Hormone and Other Cytokines
J. Biol. Chem.,
September 13, 2002;
277(38):
35240 - 35247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mattia, F. Vulcano, L. Milazzo, A. Barca, G. Macioce, A. Giampaolo, and H. J. Hassan
Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release
Blood,
February 1, 2002;
99(3):
888 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Millot, W. Vainchenker, D. Dumenil, and F. Svinarchuk
Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells
J. Cell Sci.,
January 6, 2002;
115(11):
2329 - 2337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Angchaisuksiri, S. R. Grigus, P. L. Carlson, G. W. Krystal, and E. N. Dessypris
Secretion of a unique peptide from interleukin-2-stimulated natural killer cells that induces endomitosis in immature human megakaryocytes
Blood,
January 1, 2002;
99(1):
130 - 136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Baccini, L. Roy, N. Vitrat, H. Chagraoui, S. Sabri, J.-P. L. Couedic, N. Debili, F. Wendling, and W. Vainchenker
Role of p21Cip1/Waf1 in cell-cycle exit of endomitotic megakaryocytes
Blood,
December 1, 2001;
98(12):
3274 - 3282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagata, M. Oda, H. Nakata, Y. Shozaki, T. Kozasa, and K. Todokoro
A novel regulator of G-protein signaling bearing GAP activity for G{alpha}i and G{alpha}q in megakaryocytes
Blood,
May 15, 2001;
97(10):
3051 - 3060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Debili, C. Robin, V. Schiavon, R. Letestu, F. Pflumio, M.-T. Mitjavila-Garcia, L. Coulombel, and W. Vainchenker
Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates
Blood,
April 1, 2001;
97(7):
2023 - 2030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sirven, F. Pflumio, V. Zennou, M. Titeux, W. Vainchenker, L. Coulombel, A. Dubart-Kupperschmitt, and P. Charneau
The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells
Blood,
December 15, 2000;
96(13):
4103 - 4110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lepage, M. Leboeuf, J.-P. Cazenave, C. de la Salle, F. Lanza, and G. Uzan
The alpha IIbbeta 3 integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34+ cord blood cells to megakaryocytes
Blood,
December 15, 2000;
96(13):
4169 - 4177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Axelrad, D. Eskinazi, P. N. Correa, and D. Amato
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
Blood,
November 15, 2000;
96(10):
3310 - 3321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Letestu, N. Vitrat, A. Masse, J.-P. L. Couedic, V. Lazar, P. Rameau, F. Wendling, J. Vuillier, P. Boutard, E. Plouvier, et al.
Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome
Blood,
March 1, 2000;
95(5):
1633 - 1641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gainsford, H. Nandurkar, D. Metcalf, L. Robb, C. G. Begley, and W. S. Alexander
The residual megakaryocyte and platelet production in c-Mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor
Blood,
January 15, 2000;
95(2):
528 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ishii, M. Nishihara, F. Ma, Y. Ebihara, K. Tsuji, S. Asano, T. Nakahata, and T. Maekawa
Expression of Stromal Cell-Derived Factor-1/Pre-B Cell Growth-Stimulating Factor Receptor, CXC Chemokine Receptor 4, on CD34+ Human Bone Marrow Cells Is a Phenotypic Alteration for Committed Lymphoid Progenitors
J. Immunol.,
October 1, 1999;
163(7):
3612 - 3620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sasaki, T. Takahashi, H. Miyazaki, A. Matsumoto, T. Kato, K. Nakamura, S. Iho, Y. Okuno, and K. Nakao
Production of Thrombopoietin by Human Carcinomas and Its Novel Isoforms
Blood,
September 15, 1999;
94(6):
1952 - 1960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sakamaki, Y. Hirayama, T. Matsunaga, H. Kuroda, T. Kusakabe, T. Akiyama, Y. Konuma, K. Sasaki, N. Tsuji, T. Okamoto, et al.
Transforming Growth Factor-beta 1 (TGF-beta 1) Induces Thrombopoietin From Bone Marrow Stromal Cells, Which Stimulates the Expression of TGF-beta Receptor on Megakaryocytes and, in Turn, Renders Them Susceptible to Suppression by TGF-beta Itself With High Specificity
Blood,
September 15, 1999;
94(6):
1961 - 1970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fichelson, J.-M. Freyssinier, F. Picard, M. Fontenay-Roupie, M. Guesnu, M. Cherai, S. Gisselbrecht, and F. Porteu
Megakaryocyte Growth and Development Factor-Induced Proliferation and Differentiation Are Regulated by the Mitogen-Activated Protein Kinase Pathway in Primitive Cord Blood Hematopoietic Progenitors
Blood,
September 1, 1999;
94(5):
1601 - 1613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Madoiwa, N. Komatsu, J. Mimuro, K. Kimura, M. Matsuda, and Y. Sakata
Developmental Expression of Plasminogen Activator Inhibitor-1 Associated With Thrombopoietin-Dependent Megakaryocytic Differentiation
Blood,
July 15, 1999;
94(2):
475 - 482.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Haddad, E. Cramer, C. Riviere, P. Rameau, F. Louache, J. Guichard, D. L. Nelson, A. Fischer, W. Vainchenker, and N. Debili
The Thrombocytopenia of Wiskott Aldrich Syndrome Is Not Related to a Defect in Proplatelet Formation
Blood,
July 15, 1999;
94(2):
509 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-M. Wolber, C. Dame, H. Fahnenstich, D. Hofmann, P. Bartmann, W. Jelkmann, and J. Fandrey
Expression of the Thrombopoietin Gene in Human Fetal and Neonatal Tissues
Blood,
July 1, 1999;
94(1):
97 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takahashi, N. Sekine, and T. Nakatake
Influence of Monoclonal Antiplatelet Glycoprotein Antibodies on In Vitro Human Megakaryocyte Colony Formation and Proplatelet Formation
Blood,
March 15, 1999;
93(6):
1951 - 1958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Riviere, F. Subra, K. Cohen-Solal, V. Cordette-Lagarde, R. Letestu, C. Auclair, W. Vainchenker, and F. Louache
Phenotypic and Functional Evidence for the Expression of CXCR4 Receptor During Megakaryocytopoiesis
Blood,
March 1, 1999;
93(5):
1511 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Taksin, J.-P. L. Couedic, I. Dusanter-Fourt, A. Masse, S. Giraudier, A. Katz, F. Wendling, W. Vainchenker, N. Casadevall, and N. Debili
Autonomous Megakaryocyte Growth in Essential Thrombocythemia and Idiopathic Myelofibrosis Is Not Related to a c-mpl Mutation or to an Autocrine Stimulation by Mpl-L
Blood,
January 1, 1999;
93(1):
125 - 139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Deng, N. Banu, B. Malloy, P. Hass, J. F. Wang, L. Cavacini, D. Eaton, and H. Avraham
An Agonist Murine Monoclonal Antibody to the Human c-Mpl Receptor Stimulates Megakaryocytopoiesis
Blood,
September 15, 1998;
92(6):
1981 - 1988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Poujol, D. T.-L. Roux, P. Tropel, V. Roullot, A. Nurden, G. Marguerie, and P. Nurden
Ultrastructural Analysis of Bone Marrow Hematopoiesis in Mice Transgenic for the Thymidine Kinase Gene Driven by the alpha IIb Promoter
Blood,
September 15, 1998;
92(6):
2012 - 2023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hirayama, S. Sakamaki, T. Matsunaga, T. Kuga, H. Kuroda, T. Kusakabe, K. Sasaki, K. Fujikawa, J. Kato, K. Kogawa, et al.
Concentrations of Thrombopoietin in Bone Marrow in Normal Subjects and in Patients With Idiopathic Thrombocytopenic Purpura, Aplastic Anemia, and Essential Thrombocythemia Correlate With Its mRNA Expression of Bone Marrow Stromal Cells
Blood,
July 1, 1998;
92(1):
46 - 52.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Williams, G. G. Pipia, N. S. Datta, and M. W. Long
Thrombopoietin Requires Additional Megakaryocyte-Active Cytokines for Optimal Ex Vivo Expansion of Megakaryocyte Precursor Cells
Blood,
June 1, 1998;
91(11):
4118 - 4126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Vitrat, K. Cohen-Solal, C. Pique, J. P. LeCouedic, F. Norol, A. K. Larsen, A. Katz, W. Vainchenker, and N. Debili
Endomitosis of Human Megakaryocytes Are Due to Abortive Mitosis
Blood,
May 15, 1998;
91(10):
3711 - 3723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gainsford, A. W. Roberts, S. Kimura, D. Metcalf, G. Dranoff, R. C. Mulligan, C. G. Begley, L. Robb, and W. S. Alexander
Cytokine Production and Function in c-mpl-Deficient Mice: No Physiologic Role for Interleukin-3 in Residual Megakaryocyte and Platelet Production
Blood,
April 15, 1998;
91(8):
2745 - 2752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hong, D. Dumenil, B. van der Loo, F. Goncalves, W. Vainchenker, and J. D. Erusalimsky
Protein Kinase C Mediates the Mitogenic Action of Thrombopoietin in c-Mpl-Expressing UT-7 Cells
Blood,
February 1, 1998;
91(3):
813 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Norol, N. Vitrat, E. Cramer, J. Guichard, S. A. Burstein, W. Vainchenker, and N. Debili
Effects of Cytokines on Platelet Production From Blood and Marrow CD34+ Cells
Blood,
February 1, 1998;
91(3):
830 - 843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Daw, J. T. Arnold, B. A. Abushullaih, P. E. Stenberg, M. M. White, D. Jayawardene, D. Kumar Srivastava, and C. W. Jackson
A Single Intravenous Dose of Murine Megakaryocyte Growth and Development Factor Potently Stimulates Platelet Production, Challenging the Necessity for Daily Administration
Blood,
January 15, 1998;
91(2):
466 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishida, T. Ito, and S.-i. Kuriya
Effects of C-Mpl Ligand on Cytoplasmic Maturation of Murine Megakaryocytes and on Platelet Production
J. Histochem. Cytochem.,
January 1, 1998;
46(1):
49 - 58.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Shibuya, H. Akahori, K. Takahashi, E. Tahara, T. Kato, and H. Miyazaki
Multilineage Hematopoietic Recovery by a Single Injection of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Myelosuppressed Mice
Blood,
January 1, 1998;
91(1):
37 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bunting, R. Widmer, T. Lipari, L. Rangell, H. Steinmetz, K. Carver-Moore, M. W. Moore, G.-A. Keller, and F. J. de Sauvage
Normal Platelets and Megakaryocytes Are Produced In Vivo in the Absence of Thrombopoietin
Blood,
November 1, 1997;
90(9):
3423 - 3429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Dale, J. L. Nichol, D. A. Rich, D. M. Best, S. J. Slichter, W. Sheridan, and P. Hunt
Chronic Thrombocytopenia Is Induced in Dogs by Development of Cross-Reacting Antibodies to the MpL Ligand
Blood,
November 1, 1997;
90(9):
3456 - 3461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagata, Y. Muro, and K. Todokoro
Thrombopoietin-induced Polyploidization of Bone Marrow Megakaryocytes Is Due to a Unique Regulatory Mechanism in Late Mitosis
J. Cell Biol.,
October 20, 1997;
139(2):
449 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Abraham and R. L. Basser
Megakaryocyte Growth and Development Factor: A Review of Early Clinical Studies
Oncologist,
October 1, 1997;
2(5):
311 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Neelis, L. Qingliang, G. R. Thomas, B. L. Cohen, D. L. Eaton, and G. Wagemaker
Prevention of Thrombocytopenia by Thrombopoietin in Myelosuppressed Rhesus Monkeys Accompanied by Prominent Erythropoietic Stimulation and Iron Depletion
Blood,
July 1, 1997;
90(1):
58 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Goncalves, C. Lacout, J.-L. Villeval, F. Wendling, W. Vainchenker, and D. Dumenil
Thrombopoietin Does Not Induce Lineage-Restricted Commitment of Mpl-R Expressing Pluripotent Progenitors But Permits Their Complete Erythroid and Megakaryocytic Differentiation
Blood,
May 15, 1997;
89(10):
3544 - 3553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Cramer, F. Norol, J. Guichard, J. Breton-Gorius, W. Vainchenker, J.-M. Masse, and N. Debili
Ultrastructure of Platelet Formation by Human Megakaryocytes Cultured With the Mpl Ligand
Blood,
April 1, 1997;
89(7):
2336 - 2346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Broudy, N. L. Lin, D. F. Sabath, T. Papayannopoulou, and K. Kaushansky
Human Platelets Display High-Affinity Receptors for Thrombopoietin
Blood,
March 15, 1997;
89(6):
1896 - 1904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Era, T. Takahashi, K. Sakai, K. Kawamura, and T. Nakano
Thrombopoietin Enhances Proliferation and Differentiation of Murine Yolk Sac Erythroid Progenitors
Blood,
February 15, 1997;
89(4):
1207 - 1213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Arnold, N. C. Daw, P. E. Stenberg, D. Jayawardene, D. K. Srivastava, and C. W. Jackson
A Single Injection of Pegylated Murine Megakaryocyte Growth and Development Factor (MGDF ) Into Mice Is Sufficient to Produce a Profound Stimulation of Megakaryocyte Frequency, Size, and Ploidization
Blood,
February 1, 1997;
89(3):
823 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mohle, D. Green, M. A. S. Moore, R. L. Nachman, and S. Rafii
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
PNAS,
January 21, 1997;
94(2):
663 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dolzhanskiy, R. S. Basch, and S. Karpatkin
The Development of Human Megakaryocytes: III. Development of Mature Megakaryocytes From Highly Purified Committed Progenitors in Synthetic Culture Media and Inhibition of Thrombopoietin-Induced Polyploidization by Interleukin-3
Blood,
January 15, 1997;
89(2):
426 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Kuter
Thrombopoietin: Biology and Clinical Applications
Oncologist,
February 1, 1996;
1(1):
98 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miyakawa, P. Rojnuckarin, T. Habib, and K. Kaushansky
Thrombopoietin Induces Phosphoinositol 3-Kinase Activation through SHP2, Gab, and Insulin Receptor Substrate Proteins in BAF3 Cells and Primary Murine Megakaryocytes
J. Biol. Chem.,
January 19, 2001;
276(4):
2494 - 2502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-H. Lagrue-Lak-Hal, N. Debili, G. Kingbury, C. Lecut, J.-P. Le Couedic, J.-L. Villeval, M. Jandrot-Perrus, and W. Vainchenker
Expression and Function of the Collagen Receptor GPVI during Megakaryocyte Maturation
J. Biol. Chem.,
April 27, 2001;
276(18):
15316 - 15325.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|